Sunali Wadehra, MD

Spinal cord volume loss may be a predictor of clinical outcomes in primary progressive multiple sclerosis.

Investigators assessed the effect of erenumab on total exercise time, time to exercise-induced angina, and ST depression in patients with stable angina.

Patients with increased disease activity seen on MRI or with elevated CSF NfL should be considered for disease-modifying immune therapy.

Investigators examined rates, predictors, and outcomes of neuroimaging in pediatric and adolescent patients who presented to the ED with a headache.

Investigators examined the effect of onabotulinumtoxinA on aura frequency and severity in patients with hemiplegic migraine.

Investigators examined the efficacy of oral steroids and greater occipital nerve injections as transitional therapies for cluster headache management.

Carefully assessing cognitive performance using a screening test to detect visuospatial/executive, attention, and memory dysfunction in patients with migraine.

Investigators examined baseline and 1-year variables and their association with quality of sleep in chronic tension-type headaches.

Migraine is highly prevalent in children and adolescents, affecting almost 10% of children between 5 and 15 years old and 30% of adolescents between 15 and 19 years old.

Investigators designed a parallel-group, 2-arm, randomized controlled trial to evaluate ELEVIDA, an online fatigue management program based on cognitive behavioral therapy and other therapy-based strategies.

Previous studies have shown that delayed-release DMF is safe and effective in treating RRMS in adult patients. The goal of this study was to extend these analyses to evaluate DMF in pediatric patients with RRMS.

ADS-5102 is a promising treatment option: if taken once daily at night, it achieves highest plasma drug concentrations throughout the day when symptoms are most bothersome.

Pseudobulbar affect is characterized by episodes of inappropriate laughing or crying, and may be associated with increased anxiety and depression, as well as lower mental health status.

Parkinsonism syndromes are associated with progressive disability and increased mortality, with symptom burden comparable to that of advanced cancer.